Satellos Bioscience Inc. Common Stock Cash Flow Conversion Efficiency
Satellos Bioscience Inc. Common Stock cash flow conversion efficiency. Based on the latest financial reports, Satellos Bioscience Inc. Common Stock (MSLE) has a cash flow conversion efficiency ratio of -0.131x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.83 Million) by net assets ($59.84 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Satellos Bioscience Inc. Common Stock (2007–2025)
Cash flow conversion efficiency of Satellos Bioscience Inc. Common Stock from 2007 to 2025. This chart illustrates how Satellos Bioscience Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View MSLE stock price for real-time trading data and today's change.
Satellos Bioscience Inc. Common Stock Cash Flow Conversion Ratio Explained
Satellos Bioscience Inc. Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Satellos Bioscience Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Satellos Bioscience Inc. Common Stock ranked by their cash flow conversion efficiency. Also see MSLE market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MEDIFAST INC
NYSE:MED
|
0.009x |
|
Heungkuk F&M I
KO:000540
|
0.097x |
|
Sajo Ind
KO:007160
|
-0.007x |
|
Manulife Holdings Bhd
KLSE:1058
|
-0.011x |
|
Wah Seong Corporation Bhd
KLSE:5142
|
0.074x |
|
C&C International Corp.
KQ:352480
|
0.045x |
|
Kustur Kusadasi Turizm Endustrisi AS
IS:KSTUR
|
0.056x |
|
Pine Cliff Energy Ltd
TO:PNE
|
0.107x |
Annual Cash Flow Conversion Efficiency for Satellos Bioscience Inc. Common Stock (2007–2025)
The table below shows the annual cash flow conversion efficiency of Satellos Bioscience Inc. Common Stock from 2007 to 2025. Review MSLE financial flexibility score to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $27.78 Million | $-23.60 Million | -0.849x | -130.76% |
| 2024-12-31 | $47.28 Million | $-17.40 Million | -0.368x | -3.82% |
| 2023-12-31 | $40.67 Million | $-14.42 Million | -0.354x | +79.12% |
| 2022-12-31 | $3.34 Million | $-5.66 Million | -1.698x | -253.57% |
| 2021-12-31 | $8.22 Million | $-3.95 Million | -0.480x | -105.32% |
| 2020-12-31 | $-184.25K | $-1.66 Million | 9.030x | +366.60% |
| 2019-12-31 | $678.67K | $-2.30 Million | -3.387x | -291.50% |
| 2018-12-31 | $-622.52K | $-1.10 Million | 1.769x | +407.07% |
| 2016-12-31 | $2.33 Million | $-1.34 Million | -0.576x | +29.65% |
| 2015-12-31 | $3.77 Million | $-3.09 Million | -0.819x | -59.16% |
| 2014-12-31 | $5.26 Million | $-2.71 Million | -0.514x | +82.25% |
| 2013-12-31 | $1.23 Million | $-3.57 Million | -2.898x | -115.11% |
| 2012-12-31 | $2.05 Million | $-2.77 Million | -1.347x | -87.28% |
| 2011-12-31 | $2.69 Million | $-1.93 Million | -0.719x | +35.67% |
| 2010-12-31 | $2.40 Million | $-2.68 Million | -1.118x | -126.79% |
| 2009-12-31 | $4.31 Million | $-2.12 Million | -0.493x | +78.84% |
| 2008-12-31 | $894.78K | $-2.08 Million | -2.330x | -48.35% |
| 2007-12-31 | $2.49 Million | $-3.90 Million | -1.570x | -- |
About Satellos Bioscience Inc. Common Stock
Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small m… Read more